STOCKNO.DE
Institutional ownership intelligence
Research
Schedule 13G/A

ZURA Schedule 13G/A filing by JPMorgan Chase / Asset Management

JPMorgan Chase / Asset Management reported beneficial ownership of 4.5M shares, representing 12% of Zura Bio Ltd in this filing.

FiledMay 6, 2026
Ownership dateApr 30, 2026
Reported shares4.5M
Reported ownership12%
Ownership details

Voting and dispositive power reported in the filing

These figures describe the reporting filer’s disclosed voting and investment authority. They should be read together with the reported share count and percentage.

Sole voting power 4.5M
Shared voting power 4.5M
Sole dispositive power 4.5M
Shared dispositive power 4.5M
Price context

Price dates alongside the ownership filing

Price data provides market context around the disclosure. It does not identify the filer’s actual transaction price.

Close near filing date$4.89as of May 6, 2026
Latest tracked price$5.64as of Aug 5, 2026
Source

Original filing and accession

Use the SEC filing as the primary source when you need the complete disclosure, footnotes, exhibits, or reporting-person details.

Reporting filer
JPMorgan Chase / Asset Management
CIK
CIK0000019617
Accession
0000019617-26-000157
Form
Schedule 13G/A
Open SEC filing View ZURA ownership history
Read the filing in context

Understand what a Schedule 13 filing does—and does not—tell you.

How to read a Schedule 13G → Does a 13G mean the shares were just bought? → Filing date vs. ownership date →